Bactericidal/permeability‐increasing protein promotes complement activation for neutrophil‐mediated phagocytosis on bacterial surface
- 1 August 2001
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 103 (4) , 519-525
- https://doi.org/10.1046/j.1365-2567.2001.01263.x
Abstract
Summary: The neutrophil bactericidal/permeability‐increasing protein (BPI) has both bactericidal and lipopolysaccharide‐neutralizing activities. The present study suggests that BPI also plays an important role in phagocytosis of Escherichia coli by neutrophils through promotion of complement activation on the bacterial surface. Flow cytometric analysis indicated that fluorescein‐labelled E. coli treated with BPI were phagocytosed in the presence of serum at two‐ to five‐fold higher levels than phagocytosis of the bacteria without the treatment. In contrast, phagocytosis of the fluoresceined bacteria with or without treatment by BPI did not occur at all in the absence of serum. The phagocytosis stimulated by BPI and serum was dose‐dependent. The effect of BPI on phagocytosis in the presence of serum was not observed on Gram‐positive bacteria (Staphylococcus aureus). Interestingly, the complement C3b/iC3b fragments were deposited onto the bacterial surface also as a function of the BPI concentration under conditions similar to those for phagocytosis. Furthermore, the BPI‐promoted phagocytosis was blocked completely by anti‐C3 F(ab′)2 and partially by anti‐complement receptor (CR) type 1 and/or anti‐CR type 3. These findings suggest that BPI accelerates complement activation to opsonize bacteria with complement‐derived fragments, leading to stimulation of phagocytosis by neutrophils via CR(s).Keywords
This publication has 30 references indexed in Scilit:
- Lipopolysaccharide Binding Protein from Normal Human Plasma Purified with High EfficiencyProtein Expression and Purification, 1997
- Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian CellsAnnual Review of Immunology, 1993
- Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxinCurrent Opinion in Immunology, 1993
- Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.Journal of Clinical Investigation, 1992
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.The Journal of Experimental Medicine, 1991
- Antibiotic proteins of human neutrophils.Journal of Clinical Investigation, 1990
- Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.Journal of Clinical Investigation, 1990
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990
- Resistance of Gram-negative Bacteria to Purified Bactericidal Leukocyte ProteinsJournal of Clinical Investigation, 1980